T0	Participants 151 180	patients with nasal polyposis
T1	Participants 388 528	Forty consecutive patients without laboratory or other clinical signs of allergy but with severe nasal polyposis were included in the study.
T2	Participants 529 638	Twenty patients were treated with intranasal Bdp and twenty patients received no treatment after polypectomy.
T3	Participants 643 689	patients were followed for at least 2.5 years.